# US 2024/0197212 A1 · Method and/or system for determining blood glucose reference sample times

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197212 A1
- Document ID: US20240197212A1
- Status: Published application
- Kind: A1
- Application number: 18/588,645
- Filed: 2024-02-27
- Published: 2024-06-20
- Earliest claimed: 2010-07-06
- Assignees: Medtronic MiniMed, Inc.
- Applicants: Medtronic MiniMed, Inc.
- Inventors: Rebecca K. Gottlieb; Meena Ramachandran
- Web page: https://patentgrep.com/patent/US20240197212A1

## CPC

- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/14503: {invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors (A61B5/1459, A61B5/1464, A61B5/1473, A61B5/1482, A61B5/14865 take precedence)}
- A61B 5/4839: {combined with drug delivery}
- A61B 5/6849: {in combination with a needle set}
- A61B 5/7221: {Determining signal validity, reliability or quality (preventing, reducing or removing noise induced by motion artefacts A61B5/7207; noise originating from a therapeutic or surgical apparatus A61B5/7217)}
- A61B 5/742: {using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339)}
- A61M 5/14244: {adapted to be carried by the patient, e.g. portable on the body}
- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- A61M 2005/14208: {with a programmable infusion control system, characterised by the infusion program}
- A61M 2205/18: with alarm
- A61M 2205/50: with microprocessors or computers
- A61M 2230/201: Glucose concentration
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Techniques disclose herein relate to determining glucose reference sample times. The techniques may involve determining a first glucose reference sample measurement for a patient. The techniques may further involve determining timing information for obtaining a second glucose reference sample measurement based at least in part on readings from a continuous glucose sensor.

## Claims

### Claim 1

A method comprising:
determining a first glucose reference sample measurement for a patient; and
determining timing information for obtaining a second glucose reference sample measurement based at least in part on readings from a continuous glucose sensor.

### Claim 2 (depends on 1)

The method of claim 1, wherein the first glucose reference sample measurement and the second glucose reference sample measurement are metered glucose sample measurements.

### Claim 3 (depends on 1)

The method of claim 1, wherein determining the timing information is based on a reliability of the continuous glucose sensor.

### Claim 4 (depends on 1)

The method of claim 1, further comprising causing an indication of the timing information to be presented.

### Claim 5 (depends on 4)

The method of claim 4, wherein causing the indication of the timing information to be presented comprises causing at least one of: displaying a time the second glucose reference sample measurement is to be obtained, or causing an alarm to be presented.

### Claim 6 (depends on 1)

The method of claim 1, further comprising comparing a glucose level of the patient and a predetermined target range, wherein the timing information for obtaining the second glucose reference sample measurement is based on the comparison.

### Claim 7 (depends on 6)

The method of claim 6, further comprising determining a duration of time the glucose level of the patient has been within the predetermined target range to determine the timing information .

### Claim 8 (depends on 6)

The method of claim 6, wherein the predetermined target range varies over time.

### Claim 9 (depends on 6)

The method of claim 6, wherein the glucose level is one of: an observed glucose level based on the first glucose reference sample measurement, or a predicted glucose level of the patient.

### Claim 10 (depends on 1)

The method of claim 1, wherein determining the timing information for obtaining the second glucose reference sample measurement comprises determining a duration of time to delay obtaining the second glucose reference sample measurement from a scheduled time.

### Claim 11 (depends on 1)

The method of claim 1, wherein determining the timing information comprises determining a trend of glucose levels of the patient.

### Claim 12 (depends on 1)

The method of claim 1, wherein determining the timing information comprises determining a variability of glucose levels of the patient over a previous time period.

### Claim 13

A system comprising:
one or more processors; and
one or more processor-readable media storing instructions which, when executed by one or more processors, cause performance of:
determining a first glucose reference sample measurement for a patient; and
determining timing information for obtaining a second glucose reference sample measurement based at least in part on readings from a continuous glucose sensor.

### Claim 14 (depends on 13)

The system of claim 13, wherein the first glucose reference sample measurement and the second glucose reference sample measurement are metered glucose sample measurements.

### Claim 15 (depends on 13)

The system of claim 13, wherein determining the timing information is based on a reliability of the continuous glucose sensor.

### Claim 16 (depends on 13)

The system of claim 13, wherein the one or more processors further cause performance of presenting an indication of the timing information.

### Claim 17 (depends on 16)

The system of claim 16, wherein to cause the indication of the timing information to be presented, the one or more processors further cause performance of at least one of: displaying a time the second glucose reference sample measurement is to be obtained, or presenting an alarm.

### Claim 18

A method comprising:
obtaining a first glucose reference sample measurement for a patient; and
determining timing information for obtaining a subsequent glucose reference sample measurement after the first glucose reference sample measurement to be used to calibrate a continuous glucose sensor based at least in part on a reliability of readings from the continuous glucose sensor.

### Claim 19 (depends on 18)

The method of claim 18, further comprising causing an indication of the timing information to be presented.

### Claim 20 (depends on 19)

The method of claim 19, wherein causing the indication of the timing information to be presented comprises causing at least one of: displaying a time the second glucose reference sample measurement is to be obtained, or causing an alarm to be presented.
